(2R,4S)-4-((tert-Butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95.0%, 5g

Glycine, N-2-pyrimidinyl-, methyl ester, 98%, 250mg

N-Ethoxycarbonylphthalimide [for Peptide Synthesis]>98.0%(N)100g

Benzenemethanol, 2-chloro-6-methyl-, 95.0%, 5g

(S)-N-Boc-3-Cyanomorpholine, 95.0%, 100mg

1-(4-Bromophenyl)-1,2,2-triphenylethylene>98.0%(GC)1g

Methylhydrosiloxane-dimethylsiloxane copolymer trimethylsiloxy terminated cSt 25-35, 100g

trans-4-Methoxycyclohexanol, 95%, 500mg

Piperazin-1-yl-acetonitrile dihydrochloride, 95.0%, 25g

Labels Tough Spots on the roll round, red, 9.5 mm, Gesch. for, 0.5 ml vials, 1 Roll

N-Fluoro-N'-chloromethyltriethylenediaminebis(tetrafluoroborate), 98.0%, 50g

Ethyl 2-((2,6-dimethoxyphenyl)amino)-2-oxoacetate, 98%, 5g

Di-tert-butyl piperazine-1,4-dicarboxylate, 95.0%, 1g